Karin Eastham

Karin Eastham

Presidente presso PERSONALIS, INC.

Patrimonio netto: 624 599 $ in data 31/05/2024

74 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Karin Eastham currently works at Personalis, Inc., as Chairman from 2022, Veracyte, Inc., as Independent Director from 2012, Vetica Labs, Inc., as Director, and San Diego Athena, as Director-Emeritus.
Ms. Eastham also formerly worked at Amylin Pharmaceuticals, Inc., as Independent Director from 2011 to 2012, Nektar Therapeutics, as Independent Director from 2018 to 2023, Geron Corp., as Lead Independent Director from 2018 to 2023, Illumina, Inc., as Independent Director from 2011 to 2019, Tercica, Inc., as Director from 2003 to 2008, Salmedix, Inc., as Director, Genoptix, Inc., as Director from 2008 to 2011, Cyntellect, Inc., as Director from 2000 to 2006, AltheaDx, Inc., as Independent Directors from 2014 to 2015, SGX Pharmaceuticals, Inc., as Director from 2005 to 2008, Molecular Probes, Inc., as Director from 2002 to 2003, The San Diego Symphony Orchestra Association, as Director, Trius Therapeutics, Inc., as Independent Director from 2011 to 2013, UCSD Moores Cancer Center, as Director, CombiChem, Inc., as CFO, Secretary & Senior Vice President-Finance from 1997 to 1999, Diversa Corp., as CFO, Secretary & Senior Vice President-Finance from 1999 to 2004, MorphoSys AG, as Member-Supervisory Board from 2012 to 2017, Roche Diagnostics Corp., as Vice President-Finance from 1976 to 1988, Pritsker Corp., as Vice President-Finance & Administration from 1990 to 1992, Sanford Burnham Prebys Medical Discovery Institute, as Chief Operating Officer, Trustee & Executive VP from 2004 to 2008, Cytel Corp., as CFO, Secretary & Senior Vice President-Finance from 1992 to 1997, Boehringer Mannheim Diagnostics Corp., as Vice President-Finance from 1976 to 1988, and Paper Art Co., Inc., as Vice President-Finance & Administration from 1988 to 1990.
Ms. Eastham received her undergraduate degree from Indiana University and Masters Business Admin degree from Kelley School of Business.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
13/06/2024 29 255 ( 0.04% ) 607 041 $ 31/05/2024
17/05/2024 13 506 ( 0.03% ) 17 558 $ 31/05/2024

Posizioni attive di Karin Eastham

SocietàPosizioneInizio
VERACYTE, INC. Direttore/Membro del Consiglio 01/12/2012
PERSONALIS, INC. Presidente 17/05/2022
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Tutte le posizioni attive di Karin Eastham

Precedenti posizioni note di Karin Eastham

SocietàPosizioneFine
NEKTAR THERAPEUTICS Direttore/Membro del Consiglio 08/06/2023
GERON CORPORATION Direttore/Membro del Consiglio 31/05/2023
ILLUMINA, INC. Direttore/Membro del Consiglio 29/05/2019
MORPHOSYS AG Direttore/Membro del Consiglio 01/05/2017
Direttore/Membro del Consiglio 11/09/2013
Vedi nel dettaglio l'esperienza di Karin Eastham

Formazione di Karin Eastham

Indiana University Undergraduate Degree
Kelley School of Business Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Karin Eastham

Relazioni

100 +

Relazioni di 1° grado

29

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa6
ILLUMINA, INC.

Health Technology

GERON CORPORATION

Health Technology

MORPHOSYS AG

Health Technology

VERACYTE, INC.

Health Technology

NEKTAR THERAPEUTICS

Health Technology

PERSONALIS, INC.

Health Services

Aziende private21

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Services

Commercial Services

Commercial Services

Cytel Corp.

Health Technology

Health Technology

Technology Services

Paper Art Co., Inc.

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Commercial Services

Vedi le connessioni aziendali